Span, Paul N <br/><br/>
Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success.  [electronic resource] 

 -  The Journal of pathology  Apr 2004 
 - 395-402 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-3417 
<br/><br/><label>Standard No.: </label>10.1002/path.1528  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Biomarkers, Tumor--genetics<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant<br/>Disease-Free Survival<br/>Female<br/>Gene Expression<br/>Humans<br/>Middle Aged<br/>Neoplasm Proteins--metabolism<br/>Prognosis<br/>Proportional Hazards Models<br/>RNA, Messenger--genetics<br/>RNA, Neoplasm--genetics<br/>Tamoxifen--therapeutic use<br/>Tissue Inhibitor of Metalloproteinase-3--genetics<br/>Tissue Inhibitor of Metalloproteinases--metabolism<br/>Treatment Outcome